Press Release: Miningcoop Unveils AI-Powered Cloud Mining Platform, Ushering in a New Era of Free Bitcoin Mining and Sustainable Passive Income in 2025
London, United Kingdom, May 26, 2025 (GLOBE NEWSWIRE) -- Amid global economic challenges and ongoing technological transformation, leading cryptocurrency mining platform Miningcoop has officially launched its revolutionary new AI-powered cloud mining platform. This innovative service enables users around the world to mine major cryptocurrencies like Bitcoin (BTC), Ethereum (ETH), and Litecoin (LTC) with zero hardware or upfront…
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against StubHub Holdings, Inc. (“StubHub” or the “Company”) (NYSE:STUB). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024…
LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
SAN FRANCISCO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 8th Annual Evercore Healthcare Conference, taking place in Miami, including a fireside chat on Wednesday, December 3, 2025, at 1:20 pm ET. The webcast will be available…
Boehringer Ingelheim, a global leader in preventive medicines for livestock, obtained positive opinions by the European Medicines Agency (EMA) recommending the granting of marketing authorisations under exceptional circumstances2 for its avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5. Both vaccines immunize birds against the H5 avian influenza virus, which is currently causing outbreaks across Europe.
